66096-723 NDC - LYME DISEASE SUPPORT 2 (ARGENTUM NITRICUM, ASTRAGALUS MENZIESII, CALCAREA SULPHURICA, CUPRUM ARSENICOSUM, DNA, FERRUM PHOSPHORICUM, KALI MURIATICUM, KALI SULPHURICUM, LEDUM PALUSTRE, MAGNESIA PHOSPHORICA, RNA, SILICEA.)

Drug Information

Product NDC: 66096-723

Proprietary Name: Lyme Disease Support 2

Non Proprietary Name: Argentum nitricum, Astragalus menziesii, Calcarea sulphurica, Cuprum arsenicosum, DNA, Ferrum phosphoricum, Kali muriaticum, Kali sulphuricum, Ledum palustre, Magnesia phosphorica, RNA, Silicea.

Active Ingredient(s):
  • 3 [hp_X]/59mL ASTRAGALUS NUTTALLII LEAF;
  • 6 [hp_X]/59mL CALCIUM SULFATE ANHYDROUS;
  • 12 [hp_X]/59mL CUPRIC ARSENITE;
  • 6 [hp_X]/59mL FERROSOFERRIC PHOSPHATE;
  • 4 [hp_C]/59mL HERRING SPERM DNA;
  • 6 [hp_X]/59mL MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE;
  • 6 [hp_X]/59mL POTASSIUM CHLORIDE;
  • 6 [hp_X]/59mL POTASSIUM SULFATE;
  • 1 [hp_M]/59mL RHODODENDRON TOMENTOSUM LEAFY TWIG;
  • 4 [hp_C]/59mL SACCHAROMYCES CEREVISIAE RNA;
  • 6 [hp_X]/59mL SILICON DIOXIDE;
  • 6 [hp_X]/59mL SILVER NITRATE


Administration Route(s): ORAL

Dosage Form(s): LIQUID

Pharmacy Class(es):
  • Blood Coagulation Factor [EPC];
  • Calcium [CS];
  • Calculi Dissolution Agent [EPC];
  • Cations;
  • Divalent [CS];
  • Increased Coagulation Factor Activity [PE];
  • Increased Large Intestinal Motility [PE];
  • Increased Large Intestinal Motility [PE];
  • Increased Large Intestinal Motility [PE];
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
  • Inhibition Small Intestine Fluid/Electrolyte Absorption [PE];
  • Magnesium Ion Exchange Activity [MoA];
  • Osmotic Activity [MoA];
  • Osmotic Activity [MoA];
  • Osmotic Activity [MoA];
  • Osmotic Laxative [EPC];
  • Osmotic Laxative [EPC];
  • Osmotic Laxative [EPC];
  • Potassium Compounds [CS];
  • Potassium Compounds [CS];
  • Potassium Salt [EPC];
  • Potassium Salt [EPC];
  • Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Labeler Information

Labeler Name: OHM PHARMA INC.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:11/20/2017

Package Information

No. Package Code Package Description Billing Unit
166096-723-0559 mL in 1 BOTTLE, DROPPER (66096-723-05)

NDC Record

Field Name Field Value Definition
PRODUCT NDC66096-723The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMELyme Disease Support 2The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEArgentum nitricum, Astragalus menziesii, Calcarea sulphurica, Cuprum arsenicosum, DNA, Ferrum phosphoricum, Kali muriaticum, Kali sulphuricum, Ledum palustre, Magnesia phosphorica, RNA, Silicea.The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE11/20/2017This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEOHM PHARMA INC.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEASTRAGALUS NUTTALLII LEAF; CALCIUM SULFATE ANHYDROUS; CUPRIC ARSENITE; FERROSOFERRIC PHOSPHATE; HERRING SPERM DNA; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM CHLORIDE; POTASSIUM SULFATE; RHODODENDRON TOMENTOSUM LEAFY TWIG; SACCHAROMYCES CEREVISIAE RNA; SILICON DIOXIDE; SILVER NITRATEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH3; 6; 12; 6; 4; 6; 6; 6; 1; 4; 6; 6 
ACTIVE INGRED UNIT[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_C]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_M]/59mL; [hp_C]/59mL; [hp_X]/59mL; [hp_X]/59mL 
PHARM CLASSESBlood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023